1986
DOI: 10.1159/000180318
|View full text |Cite
|
Sign up to set email alerts
|

Extrasellar Prolactinomas: Successful Management of 24 Patients Using Bromocriptine

Abstract: 24 patients with an extrasellar prolactinoma (mean prolactin 4,722 ng/ml), 8 of whom had previously had surgery, received 5–40 mg bromocriptine daily for 13–252 weeks. The mean prolactin level had fallen 89% at 2 days, 95% at 6 weeks, and 15 patients achieved normal values. Tumor shrinkage occurred in all 9 patients rescanned within 2 weeks and later was documented in 23; in 18 the extrasellar tumour disappeared. 12 patients had visual abnormalities; 7, including 2 who had been completely blind, improved withi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

1993
1993
2011
2011

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 21 publications
0
14
0
Order By: Relevance
“…Another possible reason could be associated with radiotherapy; 11 cases (85%) in Group A and 7 cases (58%) in Group B received radiotherapy. Many authors [1,2,7,[8][9][10][11][12][13][14] confirm that visual symptoms of patients with giant prolactinomas can be relieved after several days to several weeks of bromocriptine treatment.…”
Section: Discussionmentioning
confidence: 94%
See 3 more Smart Citations
“…Another possible reason could be associated with radiotherapy; 11 cases (85%) in Group A and 7 cases (58%) in Group B received radiotherapy. Many authors [1,2,7,[8][9][10][11][12][13][14] confirm that visual symptoms of patients with giant prolactinomas can be relieved after several days to several weeks of bromocriptine treatment.…”
Section: Discussionmentioning
confidence: 94%
“…Bromocriptine, which is the most commonly used D-2-receptor agonist in our clinic, can normalize the serum prolactin level and decrease the volume of the tumor in 75∼92% of the patients with prolactinomas [5][6][7][8][9][10][11][12][13][14]. The primary mechanism is the selective activation of the D-2-receptor on the cell membrane of prolactin cells, thus inhibiting the expression of the PRLm- (4A, B).…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Estimation of the prolactin level can sometimes be crucially important as some of these turnouts respond dramatically to bromocriptine therapy [31]. Although there are reports showing effectiveness of radiation treatment, there is insufficient evidence of its effects on long term outcome of these patients [22,26,34].…”
Section: Adjuvant Therapymentioning
confidence: 99%